Abstract

Magnetic Resonance Spectroscopy (MRS) enables us to assess the metabolic changes in the brain of patients with epilepsy. Therefore it can provide complementary information to structural imaging. Structural MRI plays an important role in identifying the underlying epileptogenic substrate responsible for epilepsy. MRS identifies metabolic changes in the epileptogenic brain, which could be used to lateralize seizure focus, detect bilateral brain abnormalities such as bilateral temporal lobe epilepsy, identify the metabolic abnormalities in the epileptic brain, assess metabolic abnormalities in the epileptogenic zone that appears normal on structural MRI, predict surgical outcome, and improve our understanding of the pathophysiology of epileptogenic substrate.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.